Welcome to our dedicated page for BRUNSWICK SEC filings (Ticker: BC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on BRUNSWICK's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into BRUNSWICK's regulatory disclosures and financial reporting.
Brunswick Corporation furnished an update announcing its financial results for the fourth quarter and full-year 2025, which are detailed in a separate news release attached as Exhibit 99.1.
The company highlights several non-GAAP measures, including diluted EPS as adjusted, adjusted operating earnings, free cash flow, and constant currency net sales, explaining how each metric is derived and why management finds them useful for evaluating ongoing business performance. The information is furnished rather than filed and is not automatically incorporated into other securities filings.
Brunswick Corporation is having its 6.500% Notes due 2048 removed from listing and registration on the New York Stock Exchange. The Exchange filed a Form 25 under Section 12(b) of the Securities Exchange Act of 1934, certifying it met all requirements to strike this class of securities from the NYSE. This action applies specifically to the 6.500% Notes due 2048 and reflects completion of the Exchange and issuer procedures for delisting and deregistration of this debt security.
Brunswick Corporation reported early tender results for its cash tender offer for its outstanding $300 million 5.100% Senior Notes due 2052. The company increased the maximum aggregate principal amount it is willing to purchase under the offer from $50 million to $100 million, referred to as the Tender Cap.
By the Early Tender Deadline of 5:00 p.m. Eastern Time on November 25, 2025, holders had validly tendered and not validly withdrawn $111 million aggregate principal amount of these notes. Because this amount exceeds the Tender Cap, Brunswick will purchase only $100 million of notes and apply a proration rate of approximately 90.2%, subject to minimum denominations. Settlement of accepted notes is expected on December 1, 2025, and no notes tendered after the Early Tender Deadline will be accepted, although the offer remains scheduled to expire on December 11, 2025 unless extended or earlier terminated.
Brunswick Corp (BC): Schedule 13G/A filed by Turtle Creek Asset Management Inc. The investor reported beneficial ownership of 2,926,223 shares of Brunswick common stock, representing 4.5% of the class. Turtle Creek has sole voting and dispositive power over these shares. The filing indicates the securities are held in the ordinary course and not to change or influence control. The shares are held for the benefit of unit holders of mutual funds managed by Turtle Creek, and no underlying holder is known to have more than 5% of the class.
The ownership is reported in connection with the event date September 30, 2025.
Brunswick Corporation (BC) announced a cash tender offer to purchase up to $50 million in aggregate principal amount (the “Tender Cap”) of its outstanding 5.100% Senior Notes due 2052, of which $300 million are outstanding. The offer is being made solely under an offer to purchase dated November 12, 2025, which details the terms and conditions.
This action targets partial reduction of a specific long‑dated note series. Final repurchase size will depend on noteholder participation under the stated terms.
FMR LLC and Abigail P. Johnson filed an amended Schedule 13G for Brunswick Corporation (BC), reporting beneficial ownership of 2,625,534.31 shares, or 4.0% of the common stock, as of 09/30/2025.
FMR reports sole voting power over 2,540,002.97 shares and sole dispositive power over 2,625,534.31 shares, with no shared voting or dispositive power. The filing notes ownership of 5 percent or less of the class.
The certification states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.
Brunswick Corporation (BC) reported an insider transaction by a director on 10/31/2025. The filing shows an acquisition of 1,166 shares at $66.11, identified as deferred shares that will be distributed in installments after the individual ceases serving as a director.
Following the transaction, the director beneficially owns 95,470 shares directly and 1,000 shares indirectly through a family trust. Footnotes add that direct holdings include 579 shares acquired via dividend reinvestments in September 2025.
Brunswick Corporation (BC) reported an insider transaction by a director. On 10/31/2025, the director acquired 657 shares of common stock at $66.11 (code A). Following this, the director beneficially owns 9,913 shares, held directly.
Footnotes state the acquired shares are deferred shares deposited into the director’s deferred account, to be distributed in predetermined installments after the director ceases serving on the board. Beneficial holdings include 61 shares acquired via dividend reinvestment in September 2025.
Brunswick Corporation (BC) director Reginald Fils-Aime reported acquiring 681 shares of common stock at $66.11 on 10/31/2025.
After this transaction, his directly held position totaled 10,324 shares. No derivative securities were reported.
Brunswick Corporation (BC) reported an insider transaction by director Lauren Patricia Flaherty. On 10/31/2025, 633 shares of common stock were acquired at $66.11, recorded as deferred shares deposited in a director deferred account. Following the transaction, beneficial ownership stood at 16,343 shares. Beneficial holdings include 103 shares acquired through dividend reinvestments in September 2025.